Rapid Response: The promise and peril of engineering biology, w/Ginkgo Bioworks Reshma Shetty

Topics covered
Popular Clips
Episode Highlights
Vaccine Scaling
Ginkgo Bioworks played a crucial role in scaling mRNA vaccine manufacturing, particularly through their collaboration with Moderna. explains that while mRNA vaccines were a promising solution, manufacturing them at scale was unprecedented. Ginkgo's expertise in producing precursor components and enzymes was vital in driving down costs and increasing production capacity 1.
Public Health
Ginkgo's public health initiatives included innovative approaches like classroom pool testing to combat COVID-19 spread in schools. Reshma describes how this method allowed entire classes to be tested efficiently and cost-effectively, ensuring safer school environments 2. She emphasizes the importance of biotechnology in pandemic response, highlighting Ginkgo's efforts in testing, therapeutics, and vaccine development 3.
Related Episodes


Rapid Response: Putting an end to hustle culture, w/Reshma Saujani, author of Pay Up
Answers 383 questions

Rapid Response: Inside Intel’s AI ambitions, w/CEO Pat Gelsinger
Answers 383 questions

Rapid Response: “We have an all-out cyber war right now,” w/Bipul Sinha, Rubrik CEO
Answers 383 questions

Rapid Response: How mission fuels risk-taking, with Illumina CEO Francis deSouza
Answers 383 questions

Rapid Response: Embrace tension, w/former IBM CEO Ginni Rometty
Answers 383 questions

Rapid Response: Why we need to think again, w/Adam Grant
Answers 383 questions

Rapid Response: First, be human – Thoughts on the crisis from Reid Hoffman
Answers 383 questions

Rapid Response: Why we need to think again, w/Adam Grant
Answers 383 questions

Rapid Response: 2024 is the most significant time in human history (Encore)
Answers 383 questions
